109 related articles for article (PubMed ID: 12571539)
1. Atomoxetine (strattera) for ADHD.
Med Lett Drugs Ther; 2003 Feb; 45(1149):11-2. PubMed ID: 12571539
[No Abstract] [Full Text] [Related]
2. Pharmacological treatments for ADHD and the novel agent atomoxetine.
Bailey KP
J Psychosoc Nurs Ment Health Serv; 2003 Aug; 41(8):12-7. PubMed ID: 13677007
[No Abstract] [Full Text] [Related]
3. Atomoxetine for attention deficit/hyperactivity disorder.
Garces K
Issues Emerg Health Technol; 2003 May; (46):1-4. PubMed ID: 12751480
[TBL] [Abstract][Full Text] [Related]
4. Increased blood pressure and atomoxetine.
Dworkin N
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510. PubMed ID: 15908831
[No Abstract] [Full Text] [Related]
5. Atomoxetine (Strattera) revisited.
Med Lett Drugs Ther; 2004 Aug; 46(1189):65. PubMed ID: 15314585
[No Abstract] [Full Text] [Related]
6. [Atomoxetine for the treatment of attention-deficit/hyperactivity disorder].
Davids E; Gastpar M
Fortschr Neurol Psychiatr; 2004 Oct; 72(10):586-91. PubMed ID: 15472782
[TBL] [Abstract][Full Text] [Related]
7. Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder.
Barton J
Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i26-9. PubMed ID: 15665154
[TBL] [Abstract][Full Text] [Related]
8. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
[TBL] [Abstract][Full Text] [Related]
9. An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder.
Kratochvil CJ; Bohac D; Harrington M; Baker N; May D; Burke WJ
J Child Adolesc Psychopharmacol; 2001; 11(2):167-70. PubMed ID: 11436956
[TBL] [Abstract][Full Text] [Related]
10. Atomoxetine and tics in ADHD.
Lee TS; Lee TD; Lombroso PJ; King RA
J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1068-9. PubMed ID: 15322408
[No Abstract] [Full Text] [Related]
11. Atomoxetine treatment of attention-deficit/hyperactivity disorder.
Eiland LS; Guest AL
Ann Pharmacother; 2004 Jan; 38(1):86-90. PubMed ID: 14742801
[TBL] [Abstract][Full Text] [Related]
12. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
Wigal SB; McGough JJ; McCracken JT; Biederman J; Spencer TJ; Posner KL; Wigal TL; Kollins SH; Clark TM; Mays DA; Zhang Y; Tulloch SJ
J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674
[TBL] [Abstract][Full Text] [Related]
13. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
14. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
Faraone SV; Wigal SB; Hodgkins P
J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
[TBL] [Abstract][Full Text] [Related]
15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
16. Atomoxetine in the treatment of patients with ADHD.
Gerbers JA; Allen AJ
Am Fam Physician; 2005 May; 71(10):1879-80; author reply 1880, 1882. PubMed ID: 15926406
[No Abstract] [Full Text] [Related]
17. [Atomoxetine in the treatment of ADHD].
Myhr K
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):457-8. PubMed ID: 16477285
[No Abstract] [Full Text] [Related]
18. Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD.
Adler L; Dietrich A; Reimherr FW; Taylor LV; Sutton VK; Bakken R; Allen AJ; Kelsey D
Ann Clin Psychiatry; 2006; 18(2):107-13. PubMed ID: 16754416
[TBL] [Abstract][Full Text] [Related]
19. Atomoxetine in the treatment of attention deficit hyperactivity disorder.
Kratochvil CJ; Vaughan BS; Daughton JM; Mayfield-Jorgensen ML; Burke WJ
Expert Rev Neurother; 2004 Jul; 4(4):601-11. PubMed ID: 15853579
[TBL] [Abstract][Full Text] [Related]
20. [Atomoxetine--Strattera. Oral preparation].
Duh PD; Macken E
J Pharm Belg; 2006; 61(4):117-20. PubMed ID: 17263193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
